US and Canadian Lubeluzole Ischemic Stroke Study "Lub"

Completed

Phase 3 Results

Summary of Purpose

To assess the efficacy and safety of lubeluzole in the treatment of ischemic stroke.

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 5 September 2000.

Unavailable Unavailable Unavailable Unavailable Unavailable Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Basics

Interventions

Sponsors

  • Janssen Research Foundation, Beerse, Belgium

Trial Design

Multicenter, randomized, double-blind, placebo-controlled study involving 721 patients.

Contacts

  • James Grotta, MD, Director of Stroke Program, University of Texas Health Science Center, Department of Neurology,6431 Fannin, Room 7004, Houston, TX 77030.

    jgrotta@neuro.med.uth.tmc.edu